Teva Pharmaceutical Industries Limited
55.110.80 (1.47%)
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close54.31
Bid55.10 x 600
Ask55.11 x 200
52wk Range48.01 - 71.78
Day's Range54.28 - 55.23
Avg Vol (3m)6,193,850
As of 3:46 PM EDT. NYSE Real Time Price. Market open.
  • The Wall Street Journal6 minutes ago

    [$$] Teva, Allergan Get FTC Approval for Generics Purchase

    Teva Pharmaceutical Industries Ltd. on Wednesday won regulatory approval from the Federal Trade Commission for its acquisition of Allergan PLC’s generics business, conditioned upon Teva’s divestiture of ...

  • American City Business Journals17 minutes ago

    FTC approves Teva's $40.5B deal for Allergan's generics business

    The Federal Trade Commission on Wednesday gave its approval to Teva Pharmaceutical Industries Ltd.’s proposed $40.5B acquisition of Allergan’s generics business. The approval was granted after Teva agreed to divest more than 75 generic drugs to rival businesses — marking the largest drug divestiture order in an FTC pharmaceutical merger case. “Millions of Americans rely daily on generic drugs to treat a wide range of illnesses,” said Debbie Feinstein, director of the FTC’s Bureau of Competition.